Aptamers: from bench side research towards patented molecules with therapeutic applications

Bevacizumab and Irinotecan in the Treatment of Recurrent Malignant Gliomas

(2010) John F. de Groot et al.   CANCER JOURNAL

Technical and Biological Issues Relevant to Cell Typing with Aptamers

(2009) Na Li et al.   JOURNAL OF PROTEOME RESEARCH

Recognition of biomarkers and cell-specific molecular signatures: Aptamers as capture agents

(2009) Arthur A. Nery et al.   JOURNAL OF SEPARATION SCIENCE

Rabbit antibody detection with RNA aptamers

(2008) Yoshihito Yoshida et al.   ANALYTICAL BIOCHEMISTRY

New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials

(2008) Meltem Avci-Adali et al.   BIOMATERIALS

Anticoagulation in Patients with Acute Ischemic Stroke and Atrial Fibrillation—a Balance of Risks and Benefits

(2008) Abhimanyu Beri et al.   CARDIOVASCULAR DRUGS AND THERAPY

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

(2008) Mark Y. Chan et al.   CIRCULATION

Aptamers as candidate therapeutics for cardiovascular indications

(2008) A KEEFE et al.   CURRENT OPINION IN PHARMACOLOGY

A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor

(2008) M. Y. CHAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS